Revolutionary therapy treats ‘untreatable’ blood cancer
A world-first gene therapy which turns white blood cells into a disease-busting “living drug” has reversed previously untreatable…
Jordan-trained pharmacists arrive in N.S. following international recruitment
Listen to this article Estimated 4 minutes The audio version of this article is generated by AI-based technology.…
One engineer’s quest to reconstruct hope for breast cancer survivors
Katie Weimer, a biomechanical engineer based in Colorado, was challenged by her mentor to think bigger — to…
This Toronto doctor has over 2,000 patients, but still no permanent residency
LISTEN | White Coat, Black Art with Dr. Brian Goldman: White Coat Black Art26:30The MD with over 2,000…
Americans living longer after cancer diagnosis — Harvard Gazette
New findings on cancer survival rates offer hope for the more than 2 million Americans diagnosed each year.…
Alberta heart, cancer patients waiting too long for critical surgery, health experts warn
More Albertans are waiting longer than clinically recommended for critical cardiac and cancer surgeries, sparking concern among health…
How China rewrote the rules of drug innovation
In an era where AI-driven drug discovery accelerates candidate generation faster than traditional systems can evaluate them, regulatory…
The headline trap—Why ‘shocking’ health headlines are usually wrong
Over the past few years, access to health research has become easier than ever, yet understanding it seems…
Getting a helping hand to remain independent with dementia – and what to look for when choosing a care home
Ensuring there’s access to support can be crucial for the person with dementia – and the people caring…
Elder care industry braces for loss of many Haitian immigrant workers
Colin O’Leary recently had the toughest day of his career. The executive director at Laurel Ridge Rehabilitation &…
The Measles Comeback Gets Worse
Staffers from a pediatric medicine office in Spartanburg, South Carolina, on January 30, 2026 assess a patient with…
CMS selects next batch of 15 high-cost medicines for third negotiation cycle
Gilead’s HIV treatment Biktarvy is the top-selling drug on the list, generating 2024 sales of $13.4bn. Ant Photo…